JP2004509858A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509858A5
JP2004509858A5 JP2002516054A JP2002516054A JP2004509858A5 JP 2004509858 A5 JP2004509858 A5 JP 2004509858A5 JP 2002516054 A JP2002516054 A JP 2002516054A JP 2002516054 A JP2002516054 A JP 2002516054A JP 2004509858 A5 JP2004509858 A5 JP 2004509858A5
Authority
JP
Japan
Prior art keywords
antibody
prp
ungulate
natural
binding affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002516054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509858A (ja
Filing date
Publication date
Priority claimed from US09/627,218 external-priority patent/US6537548B1/en
Application filed filed Critical
Publication of JP2004509858A publication Critical patent/JP2004509858A/ja
Publication of JP2004509858A5 publication Critical patent/JP2004509858A5/ja
Pending legal-status Critical Current

Links

JP2002516054A 2000-07-27 2001-07-17 有蹄類PrPに特異的な抗体 Pending JP2004509858A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/627,218 US6537548B1 (en) 2000-07-27 2000-07-27 Antibodies specific for ungulate PrP
PCT/US2001/022648 WO2002010335A2 (en) 2000-07-27 2001-07-17 ANTIBODIES SPECIFIC FOR UNGULATE PrP

Publications (2)

Publication Number Publication Date
JP2004509858A JP2004509858A (ja) 2004-04-02
JP2004509858A5 true JP2004509858A5 (enExample) 2005-08-25

Family

ID=24513726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002516054A Pending JP2004509858A (ja) 2000-07-27 2001-07-17 有蹄類PrPに特異的な抗体

Country Status (6)

Country Link
US (3) US6537548B1 (enExample)
EP (1) EP1368644A2 (enExample)
JP (1) JP2004509858A (enExample)
AU (2) AU7597701A (enExample)
CA (1) CA2416029A1 (enExample)
WO (1) WO2002010335A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003085086A2 (en) * 2002-04-09 2003-10-16 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
GB0402123D0 (en) * 2004-01-30 2004-03-03 Protherics Plc Method
US20050256425A1 (en) 2004-05-11 2005-11-17 Inpro Biotechnology, Inc. Device, system and method for extracting and preparing brain tissue
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
WO2006102099A2 (en) * 2005-03-18 2006-09-28 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
WO2014025785A2 (en) * 2012-08-06 2014-02-13 Trustees Of Boston University Prion protein ligands as therapeutic agents for neurodegenerative disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246462A (enExample) * 1959-08-06
US4806627A (en) 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
US5908969A (en) 1994-05-13 1999-06-01 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US5792901A (en) 1994-05-13 1998-08-11 The Regents Of The University Of California Detecting prions in a sample and prion preparation and transgenic animal used for same
EP1416280A3 (en) 1995-09-14 2005-08-10 The Regents of the University of California Antibodies specific for native PrPsc
US5891641A (en) 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
DE69909442T2 (de) * 1998-02-20 2004-04-22 The Regents Of The University Of California, Oakland Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen
US6528269B1 (en) 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
US6261790B1 (en) * 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
BR0012765A (pt) 1999-07-27 2002-04-02 Imp College Innovations Ltd Peptìdeo, métodos de fabricar um anticorpo, de fabricar um agente de ligação capaz de ligar-se a uma forma celular de uma proteìna de prion, de remover uma forma celular de uma proteìna de prion de uma amostra, e de usar um anticorpo e/ou agente de ligação, anticorpo, agente de ligação, uso de um anticorpo ou agente de ligação, kit, e , sequência de peptìdeo de uma forma celular de uma proteìna de prion

Similar Documents

Publication Publication Date Title
Lowenthal et al. Quantitative bottom-up proteomics depends on digestion conditions
JP6951417B2 (ja) アフィニティークロマトグラフィーのためのFC−結合タンパク質、並びにFc−結合タンパク質を含むアフィニティー分離マトリックスおよびその使用
Hao et al. Enhanced separation and characterization of deamidated peptides with RP-ERLIC-based multidimensional chromatography coupled with tandem mass spectrometry
JP2003505025A5 (enExample)
Stefanescu et al. Mass spectrometric approaches for elucidation of antigen—antibody recognition structures in molecular immunology
JP2009540838A5 (enExample)
ATE468127T1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
JP7573287B2 (ja) アフィニティー精製用免疫グロブリン結合タンパク質
EP3911947B1 (en) Method and system of identifying and quantifying antibody fragmentation
Perez Hurtado et al. Deamidation of collagen
JP2010197110A (ja) 質量分析装置を用いたタンパク質定量のための評価用ペプチド、人工標準タンパク質、及びタンパク質の定量方法
Schuster et al. Short cut of protein purification by integration of cell-disrupture and affinity extraction
WO2005010023A3 (en) Method for prediction of an epitope
JP2002544237A5 (enExample)
US11208436B2 (en) Populations of polypeptides having a triple-helical structure
WO2003018797A3 (en) Method and device for integrated protein expression, purification and detection
Soloviev et al. Peptidomics, current status
CA2542104A1 (en) Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
JP6781854B1 (ja) モノクローナル抗体の酵母による製造方法およびスクリーニング方法
JP2005512016A5 (enExample)
CA2432995A1 (en) Immunogenic hla-a2 supermotif-restricted peptides
RU2010145185A (ru) Селективное обогащение модифицированных по n-концу пептидов из сложных образцов
EP0331514A3 (en) Assaying the duchenne muscular dystrophy protein deletion or defect
CN113121669B (zh) 一种人脂联素的抗原模拟表位及制备方法
WO2006086288A3 (en) Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells